Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8680445 | Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | 2016 | 10 Pages |
Abstract
PEs exert a relevant effect in cognitive outcomes at retest and, accordingly, they must be taken into consideration in clinical trials. The magnitude of PE in processing speed and working memory could be of special interest for the development of cognitive markers of preclinical AD.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Gonzalo Sánchez-Benavides, Juan D. Gispert, Karine Fauria, José Luis Molinuevo, Nina Gramunt,